Ifp Advisors, Inc Clearside Biomedical, Inc. Transaction History

Ifp Advisors, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$1.1 - $1.74 $4,510 - $7,134	-4,100 Closed	0 $0
Q4 2018 Jan 23, 2019	BUY	$1.0 - $6.12 $2,000 - $12,240	2,000 Added 95.24%	4,100 $4,000
Q3 2018 Oct 25, 2018	BUY	$6.03 - $11.24 $9,045 - $16,860	1,500 Added 250.0%	2,100 $0
Q1 2018 May 09, 2018	BUY	$5.57 - $14.28 $3,342 - $8,568	600 New	600 $0

12.2M

54.7K

50.7K

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $59.6M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.